In the News

The widely held belief that gout is primarily caused by diet is questionable, according to a study published in the BMJ.

The study suggests that diet is substantially less important than genes in the development of high serum urate levels that often precede gout.

To better...

NEW YORK -- April 5, 2018 -- Use of certolizumab pegol (CZP), an anti-tumour necrosis factor medication (anti-TNF) approved for treatment of rheumatic diseases and/or Crohn’s disease, appears safe during pregnancy, according to a study published in Arthritis & Rheumatology.

“In this...

BETHESDA, Md -- April 11, 2018 -- Researchers have worked with 15 patients from around the world to uncover a genetic basis of melorheostosis, also known as “dripping candle wax” bone disease.

The results, published in Nature Communications, offer potential treatment targets for...

ROCKVILLE, Md -- April 17, 2018 -- The US Food and Drug Administration (FDA) has approved burosumab (Crysvita), the first drug approved to treat adults and children aged 1 year and older with x-linked hypophosphatemia (XLH).

“XLH differs from other forms of rickets in that vitamin D...

SAN DIEGO -- May 15, 2018 -- Researchers have decoded the epigenetic landscape for rheumatoid arthritis (RA), and in this unveiling, simultaneously discovered an overlap between the causes of RA and Huntington’s disease.

The unexpected finding, published in Nature Communications,...

PHILADELPHIA -- May 22, 2018 -- Evidence-based recommendations have stopped or reversed trends towards the increased use of injections for knee osteoarthritis (OA), but these treatments are still commonly used, reports a study in The Journal of Bone & Joint Surgery.

In the...

MONTREAL -- May 18, 2018 -- A new study led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC) has revealed that pregnant women with rheumatoid arthritis (RA) may be able to use tumour necrosis factors inhibitors (TNFi). without possible increased health risks...

Fractures among older people increase their risk of death for up to 10 years, according to a published in the Journal of Clinical Endocrinology & Metabolism.

Hip fractures are known to increase the mortality risk among older people; however, the current study is the first to...

A new positron emission tomography (PET) imaging method more fully evaluates the extent of rheumatoid arthritis (RA) by targeting translocator protein (TSPO) expression in the synovium, according to a study published in the July issue of The Journal of Nuclear Medicine.

PET...

Upadacitinib is effective in patients with moderate to severe forms of rheumatoid arthritis who have shown an inadequate response to conventional disease modifying drugs, according to a study published in The Lancet.

For the study, Gerd-Rüdiger Burmester, MD, Charité - University...

Pages